Management of symptoms in step-down therapy of gastroesophageal reflux disease

Journal of Gastroenterology and Hepatology (Australia)

Volumn 20, Issue 9, 2005, Pages 1365-1370

  Mine, Shinichiro ^a,b,d   Iida, Takeshi ^b,c   Tabata, Takahiro ^b   Kishikawa, Hirofumi ^b   Tanaka, Yoshiya ^b  

^a Shin Nakama Hospital   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c YAMAGUCHI ROSAI HOSPITAL   (Japan)

^d UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Gastroesophageal reflux disease; Lansoprazole; Quality of life

Indexed keywords

FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; PROTON PUMP INHIBITOR; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; DRUG DERIVATIVE; ENZYME INHIBITOR; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; OMEPRAZOLE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; DISEASE CLASSIFICATION; DRUG EFFICACY; DYSPHAGIA; ENDOSCOPE; ENDOSCOPIC ECHOGRAPHY; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SYMPTOM; HEARTBURN; HUMAN; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; REFLUX ESOPHAGITIS; TREATMENT OUTCOME; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ANTAGONISM; ECHOGRAPHY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; AGED; DEGLUTITION DISORDERS; ENDOSONOGRAPHY; ENZYME INHIBITORS; ESOPHAGITIS, PEPTIC; FAMOTIDINE; FEMALE; GASTROESOPHAGEAL REFLUX; H(+)-K(+)-EXCHANGING ATPASE; HEARTBURN; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; QUALITY OF LIFE; RECURRENCE; TREATMENT OUTCOME;

EID: 29244457772     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2005.03980.x     Document Type: Article

References (18)

1. Gerson LB, Edson R, Lavori PW et al. Use of a simple symptom questionnaire to predict Barrett's esophagus in patients with symptoms of gastroesophageal reflux. Am. J. Gastroenterol. 2001 96 : 2005 12.
2. Spechler SJ. Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion 1992 51 (Suppl. 1 69 73.
3. Lauritsen K. Management of endoscopy-negative reflux disease: progress with short-term treatment. Aliment. Pharmacol. Ther. 1997 11 (Suppl. 2 87 92.
4. Mine S, Fujisaki T, Tabata T et al. Ultrasonographic evaluation of lansoprazole-induced improvement of submucosal injury in patients with gastroesophageal reflux. Am. J. Gastroenterol. 2000 95 : 381 6.
5. Havelund T, Aalykke C. The efficacy of a pectin-based raft-forming anti-reflux agent in endoscopy-negative reflux disease. Scand. J. Gastroenterol. 1997 32 : 773 7.
6. Armstrong D, Bennett JR, Blum AL et al. The endoscopic assessment of esophagus: a progress report on observer agreement. Gastroenterology 1996 111 : 85 92.
7. Dupuy HJ. The psychological general well-being (PGWB) index. In: Wenger NK, Mattson ME, Furberg CF, Elinson J, eds. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York : Le Jacq Publishing, 1984 170 83.
8. Dimenas E, Glise H, Hallerback B et al. Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Scand. J. Gastroenterol. 1993 28 : 681 7.
9. Havelund T, Lind T, Wiklund I et al. Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole. Am. J. Gastroenterol. 1999 94 : 1782 9.
10. el-Omar EM, Banerjee S, Wirz A et al. The Glasgow Dyspepsia Severity Score - a tool for the global measurement of dyspepsia. Eur. J. Gastroenterol. Hepatol. 1996 8 : 967 71.
11. Beck IT. In support of 'step-up therapy' for gastroesophageal reflux disease. Am. J. Gastroenterol. 2002 97 : 503 4.
12. Inadomi JM. On-demand and intermittent therapy for gastro-oesophageal reflux disease: economic considerations. Pharmacoeconomics 2002 20 : 565 76.
13. Pohland CJ, Scavnicky SA, Lasky SS et al. Lansoprazole overutilization: methods for step-down therapy. Am. J. Manag. Care 2003 9 : 353 8.
14. Howden CW, Henning JM, Huang B et al. Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies. Am. J. Gastroenterol. 2001 96 : 1704 10.
15. Richter JE, Kovacs TOG, Greski-rose PA et al. Lansoprazole in the treatment of heartburn in patients without erosive oesophagitis. Aliment. Pharmacol. Ther. 1999 13 : 795 804.
16. Galmiche JP, Barthelemy P, Hamelin B. Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Aliment. Pharmacol. Ther. 1997 11 : 765 73.
17. Ohara T, Arakawa T. Lansoprazole decreases peripheral blood monocytes and intercellular adhesion molecule-1-positive mononuclear cells. Dig. Dis. Sci. 1999 44 : 1710 15.
18. Yoshida N, Yoshikawa T, Tanaka Y et al. A new mechanism for anti-inflammatory actions of proton pump inhibitors - inhibitory effects on neutrophil-endothelial cell interactions. Aliment. Pharmacol. Ther. 2000 14 (Suppl. 1 74 81.